Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB386892

Renalase Antibody (RNLS/1940), DyLight 350, Novus Biologicals™
SDP

Catalog No. NB386892 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB386892 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB386892 Supplier Novus Biologicals Supplier No. NBP308450UV
Only null left
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Renalase Monoclonal antibody specifically detects Renalase in Human samples. It is validated for ELISA

Specifications

Antigen Renalase
Applications ELISA
Classification Monoclonal
Clone RNLS/1940
Conjugate DyLight 350
Formulation 50mM Sodium Borate
Gene Alias C10orf59chromosome 10 open reading frame 59, EC 1.4, FLJ11218, MAO-C, Monoamine oxidase-C, RENALASE, renalase, FAD-dependent amine oxidase
Host Species Mouse
Immunogen Recombinant human Renalase protein fragment (around aa 34-235) (exact sequence is proprietary) (Uniprot: Q5VYX0)
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Lipid and Metabolism
Primary or Secondary Primary
Gene ID (Entrez) 55328
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.